-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Avalo Therapeutics, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2017 to Q2 2022.
- Avalo Therapeutics, Inc. Selling and Marketing Expense for the quarter ending June 30, 2022 was $2.8M, a 250% increase year-over-year.
- Avalo Therapeutics, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2022 was $6.29M, a 180% increase year-over-year.
- Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2021 was $2.83M, a 20.7% increase from 2020.
- Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2020 was $2.34M, a 57.7% increase from 2019.
- Avalo Therapeutics, Inc. annual Selling and Marketing Expense for 2019 was $1.48M, a 172% increase from 2018.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)